指南与共识湿疹皮炎与荨麻疹

结合治疗达标原则与共享决策:特应性皮炎最小疾病活动度标准的国际专家共识建议

Combining treat-to-target principles and shared decision-making: International expert consensus-based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis.
指南 / 共识 · J Eur Acad Dermatol Venereol · 2024-07-11

国际专家基于全球患者研究和87位皮肤科专家意见,采用改良eDelphi投票制定AHEAD建议,提出结合共享决策与最小疾病活动度(MDA)概念的特应性皮炎管理新方法,所有建议均达成共识。

要点

  • AHEAD建议强调患者选择最困扰的AD特征,医生据此选择对应的患者报告严重度测量和客观严重度测量。
  • 治疗目标从「中等」和「最佳」目标列表中选择,达成「最佳」目标即定义为MDA。
  • 所有建议在1轮投票中达成共识(≥70%同意),其中30/34条达成强共识(≥90%同意)。

核心结论

  • AHEAD建议建立了结合共享决策和MDA概念的特应性皮炎管理新方法。

研究设计与样本

  • 国际专家皮肤科医生小组基于全球患者研究和来自44个国家的87位专家皮肤科医生的见解起草建议,采用改良eDelphi投票流程对建议进行投票。

主要发现

  • 所有建议在1轮投票中达成共识(≥70%同意),30/34条建议达成强共识(≥90%同意)。

关键数值与推荐

  • 患者选择最困扰的AD特征,临床医生选择对应的患者报告严重度测量和客观严重度测量。
  • 治疗目标从「中等」和「最佳」目标列表中选择,达成「最佳」目标定义为MDA。

临床怎么用

  • 临床中可应用AHEAD建议,通过共享决策让患者参与选择最困扰的AD特征和治疗目标,并以MDA作为治疗达标标准。

局限性

  • 患者未参与用于生成每条建议共识的eDelphi投票过程,但专家在初始起草建议时考虑了全球定性患者研究中的患者观点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current treat-to-target recommendations for atopic dermatitis (AD) may not include high enough treatment targets and do not fully consider patient needs. OBJECTIVE: To develop recommendations for optimized AD management, including disease severity assessments, treatment goals and targets, and guidance for treatment escalation/modification. METHODS: An international group of expert dermatologists drafted a series of recommendations for AD management using insights from a global patient study and 87 expert dermatologists from 44 countries. Experts voted on recommendations using a modified eDelphi voting process. RESULTS: The Aiming High in Eczema/Atopic Dermatitis (AHEAD) recommendations establish a novel approach to AD management, incorporating shared decision-making and a concept for minimal disease activity (MDA). Consensus (≥70% agreement) was reached for all recommendations in 1 round of voting; strong consensus (≥90% agreement) was reached for 30/34 recommendations. In the AHEAD approach, patients select their most troublesome AD feature(s); the clinician chooses a corresponding patient-reported severity measure and objective severity measure. Treatment targets are chosen from a list of 'moderate' and 'optimal' targets, with achievement of 'optimal' targets defined as MDA. CONCLUSIONS: Patient and expert insights led to the development of AHEAD recommendations, which establish a novel approach to AD management. Patients were not involved in the eDelphi voting process used to generate consensus on each recommendation. However, patient perspectives were captured in a global, qualitative patient research study that was considered by the experts in their initial drafting of the recommendations.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Silverberg JI, Gooderham M, Katoh N, et al. Combining treat-to-target principles and shared decision-making: International expert consensus-based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis. J Eur Acad Dermatol Venereol. 2024. PMID: 38989857. doi:10.1111/jdv.20229

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。